Dimensional Fund Advisors LP Iveric Bio, Inc. Transaction History

Dimensional Fund Advisors LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$26.24 - $39.63 $3.95 Million - $5.96 Million	-150,437 Reduced 10.85%	1,236,096 $48.6 Million
Q1 2023 May 12, 2023	SELL	$18.67 - $24.56 $891,343 - $1.17 Million	-47,742 Reduced 3.33%	1,386,533 $33.7 Million
Q4 2022 Feb 09, 2023	SELL	$17.24 - $23.95 $2.15 Million - $2.99 Million	-124,938 Reduced 8.01%	1,434,275 $30.7 Million
Q3 2022 Nov 10, 2022	BUY	$9.4 - $18.59 $2.38 Million - $4.7 Million	252,924 Added 19.36%	1,559,213 $28 Million
Q2 2022 Aug 12, 2022	BUY	$9.12 - $18.9 $2.37 Million - $4.91 Million	260,041 Added 24.85%	1,306,289 $12.6 Million
Q1 2022 May 13, 2022	SELL	$12.15 - $16.83 $488,928 - $677,256	-40,241 Reduced 3.7%	1,046,248 $17.6 Million
Q4 2021 Feb 09, 2022	SELL	$13.83 - $18.78 $160,428 - $217,848	-11,600 Reduced 1.06%	1,086,489 $18.2 Million
Q3 2021 Nov 12, 2021	BUY	$7.07 - $17.5 $3.94 Million - $9.75 Million	557,211 Added 103.02%	1,098,089 $17.8 Million
Q2 2021 Aug 12, 2021	BUY	$5.69 - $7.17 $1.53 Million - $1.93 Million	269,640 Added 99.41%	540,878 $3.41 Million
Q1 2021 May 14, 2021	SELL	$5.08 - $6.89 $49,697 - $67,404	-9,783 Reduced 3.48%	271,238 $1.67 Million
Q4 2020 Feb 25, 2021	BUY	$5.65 - $7.66 $1.59 Million - $2.15 Million	281,021 New	281,021 $1.94 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.